Medical device recalls Moderate risk

Fisher Diagnostics recalls Pacific Hemostasis FDP (Fibrinogen Degradation Products) Assay Kit (30 Determinations), REF/Model 100650, UDI 008452750…

Recall date
May 19, 2017
Source
U.S. Food & Drug Administration (FDA) — enforcement report
Recall number
Z-2762-2017
FDA classification
Class II
Brand / firm
Fisher Diagnostics
Sold / distributed
USA (nationwide) including Puerto Rico, and Internationally to Colombia

Why it was recalled

An issue was discovered with the Pacific Hemostasis Fibrinogen Degradation Products (FDP) kit, list number 100650, lot 948546 and FDP Latex Reagent, list 100651, lot 890199. While the kit performs accurately at FDP concentrations greater than 20 ¿g/ml, there is an observed reduction in sensitivity when FDP levels are less than 20 ¿g/ml. This reduction in sensitivity has been tied to FDP Latex Reagent lot 890199 and may result in false negatives.

Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What was recalled

Pacific Hemostasis FDP (Fibrinogen Degradation Products) Assay Kit (30 Determinations), REF/Model 100650, UDI 00845275000863, IVD; --- Fisher Diagnostics, a division of Fisher Scientific Company LLC ,a part of Thermo Fisher Scientific Inc., Middletown, VA 22645-1905 USA --- For determination of Fibrinogen Degradation products in serum and urine.

Get recall alerts

Free email alert whenever Fisher Diagnostics has a new recall — straight from official government data. Unsubscribe anytime.

More recalls from: Fisher Diagnostics